Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statements on Forms S-3 (Nos.
333-146171, 333-113015, 333-112123, 333-88726, 333-44298, 333-40408, 333-89159, 333-75175 and
333-74775), and Forms S-8 (Nos. 333-158375, 333-149108, 333-144516, 333-130454, 333-67384,
333-67386, 333-80065, 333-80067 and 333-80069) of Alseres Pharmaceuticals, Inc. and Subsidiaries of
our report dated March 31, 2010, relating to our audit of the consolidated financial statements,
which appears in the Annual Report on Form 10-K of Alseres Pharmaceuticals, Inc. and Subsidiaries
for the year ended December 31, 2009. Our report dated March 31, 2010, relating to the
consolidated financial statements includes an emphasis paragraph relating to an uncertainty as to
the Companys ability to continue as a going concern.
/s/ McGladrey & Pullen, LLP
Burlington, MA
March 31, 2010
March 31, 2010